BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6014733)

  • 21. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
    Fritsch H; Bachmann GW; Lenhard J
    Med Klin; 1969 May; 64(18):842-7. PubMed ID: 4389564
    [No Abstract]   [Full Text] [Related]  

  • 22. Clonidine (Catapres): a new antihypertensive agent.
    Khan A; Camel G; Perry HM
    Curr Ther Res Clin Exp; 1970 Jan; 12(1):10-8. PubMed ID: 4984047
    [No Abstract]   [Full Text] [Related]  

  • 23. [First clinical experiences with a new hypotensive substance in severe forms of hypertension].
    Bergström J; Bergquist-Poppen M; Bucht H
    Arzneimittelforschung; 1966 Dec; 16(12):1606-10. PubMed ID: 6014792
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experiences with 2-(2,6-dichlorphenylamino)-2-imidazolinhydrochloride in renal hypertension].
    Kotzaurek R; Schmidt P; Widhalm F
    Wien Klin Wochenschr; 1970 Nov; 82(45):805-9. PubMed ID: 5479019
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
    Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
    Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the efficacy of onosma in experimental hypertension].
    Larin AP; Aleutskiĭ NN
    Farmakol Toksikol; 1967; 30(6):694-6. PubMed ID: 5598439
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinico-experimental study of a hypotensive drug: 2(2,6-dichloro-phenylamino)-2-imidazoline hydrochloride].
    Caparello O; Contino A; Viola A; Pirro G
    Clin Ter; 1971 Jul; 57(6):553-62. PubMed ID: 5136489
    [No Abstract]   [Full Text] [Related]  

  • 28. [Catapresan--a new hypotensive agent].
    Tarkowska A
    Pol Tyg Lek; 1969 Jun; 24(24):934-6. PubMed ID: 4896410
    [No Abstract]   [Full Text] [Related]  

  • 29. Angiotensin II receptors and angiotensin II receptor antagonists.
    Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
    Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
    [No Abstract]   [Full Text] [Related]  

  • 30. [The use of melaxen in combined therapy of arterial hypertension in subjects occupied in assembly line production].
    Zamotaev IuN; Enikeev AKh; Kolomoets NM
    Klin Med (Mosk); 2009; 87(6):46-9. PubMed ID: 19670717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experience in the clinical use of an imidazoline derivative with varying application].
    Teichmann G; Riethling AK; Harms R; Wagner HD; Wedler B; Schröder K
    Dtsch Gesundheitsw; 1970 May; 25(21):971-5. PubMed ID: 5509007
    [No Abstract]   [Full Text] [Related]  

  • 32. [Long-term drug therapy of arterial hypertension including patient compliance].
    Linss G; Kiesewetter R
    Z Arztl Fortbild (Jena); 1984; 78(24):1047-53. PubMed ID: 6442069
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sanegyt therapy of moderately severe and severe arterial hypertension].
    Stankusheva G; Elenkova A
    Vutr Boles; 1981; 20(2):81-7. PubMed ID: 7257337
    [No Abstract]   [Full Text] [Related]  

  • 34. [New, in Austria registered specialty drugs. Normoxin (moxonidine)].
    Kögler H; Raneburger J
    Wien Klin Wochenschr; 1993; 105(3):94-6. PubMed ID: 8447129
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical experimentation with a new anti-hypertensive agent (St 155)].
    Vettore L
    Minerva Med; 1972 Apr; 63(29):1669-78. PubMed ID: 5025774
    [No Abstract]   [Full Text] [Related]  

  • 36. Properties of catapres, a new hypotensive drug: a preliminary report.
    Ng J; McGrgor DD; Taylor KM; Smirk H
    N Z Med J; 1967 Dec; 66(425):864-70. PubMed ID: 5236015
    [No Abstract]   [Full Text] [Related]  

  • 37. Diazoxide in the treatment of hypertension.
    Nellen M
    S Afr Med J; 1970 Jan; 44(5):106-8. PubMed ID: 4906221
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular effects of a new antihypertensive agent in several species.
    Salvati P; Caravaggi AM; Lamberti E; Monteggia M; Bianchi G
    Arzneimittelforschung; 1983; 33(8):1098-106. PubMed ID: 6685486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on the effect of dichlorphenylaminoimidazoline (Haemiton) in arterial hypertension].
    Thiel H; Mitschke H
    Dtsch Gesundheitsw; 1970 Nov; 25(45):2109-15. PubMed ID: 5487971
    [No Abstract]   [Full Text] [Related]  

  • 40. Effective antihypertensive therapy: blood pressure control with moxonidine.
    Prichard BN; Graham BR
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S38-48. PubMed ID: 8872298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.